Hyperfine, Inc. (HYPR) vs Sera Prognostics, Inc. (SERA)
Hyperfine, Inc. and Sera Prognostics, Inc. are both Medical Devices companies. Hyperfine, Inc. and Sera Prognostics, Inc. are of similar size ($84.4M and $83.2M). Hyperfine, Inc. grew revenue faster over the last twelve months: 53.2% against −35.2%. Hyperfine, Inc. has the higher net margin (−210.8% vs −47,475.7%) and the lower return on invested capital (−401.8% vs −180.2%). Across the 18 metrics below, Hyperfine, Inc. leads on 10 and Sera Prognostics, Inc. on 8.
Valuation
Profitability
| Metric | HYPR | SERA | Medical Devices median |
|---|---|---|---|
| Gross margin | 51.41% | (150.00%) | 56.01% |
| Operating margin | (203.27%) | (53,282.86%) | (15.03%) |
| Net margin | (210.75%) | (47,475.71%) | (20.40%) |
| Free cash flow margin | (166.48%) | (40,760.00%) | (7.24%) |
| Return on equity | (96.97%) | (45.03%) | (15.32%) |
| Return on assets | (64.40%) | (33.47%) | (19.72%) |
| Return on invested capital | (401.79%) | (180.22%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack